OASAS is temporarily waiving certain rules and regulations to ensure maximum flexibility and support for certified and/or funded providers. Issued 3/20/20. Updated 7/24/20.
Frequently asked questions and recommendations to support Opioid Treatment Programs (OTPs) operating in the wake of the evolving COVID-19 situation in New York State.
Certified/funded prevention programs are permitted to provide telepractice services (telephonically and/or audiovisually) if a school district or building closes in relation to the COVID-19 emergency.
Guidance outlining an update to the telepractice service waiver to include peer services provided by a Certified Recovery Peer Advocates during the COVID-19 emergency.
Patients may now be initiated on buprenorphine through the use of telepractice in accordance with DEA guidance that is in effect during the state of emergency.
NYS Department of Health has issued additional Medicaid pharmacy guidance regarding the declared Disaster Emergency in the State of New York over COVID-19.
OASAS is waiving certain regulatory requirements for providing telepractice services amidst the COVID-19 outbreak. Complete and return the attached attestation form to begin providing services.
